- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
246
13 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
246 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALNY | US$271.31 | -2.7% | 56.8% | US$35.7b | US$299.74 | PS16.7x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$59.88 | -0.4% | 116.2% | US$20.4b | US$62.47 | PE138.6x | E29.7% | n/a | Consumer Durables | ||
ARES | US$198.22 | 0.5% | 57.1% | US$62.0b | US$195.00 | PE92.6x | E38.4% | 1.9% | Diversified Financials | ||
NVDA | US$120.07 | -15.8% | 81.5% | US$3.1t | US$173.78 | PE46.6x | E21.8% | 0.03% | Semiconductors | ||
NU | US$13.24 | 7.3% | 41.3% | US$64.6b | US$15.06 | PB8.3x | E25.2% | n/a | Banks | ||
MRVL | US$112.86 | -9.0% | 67.1% | US$95.5b | US$129.25 | PS18.2x | E55.6% | 0.2% | Semiconductors | ||
ITCI | US$127.08 | -0.2% | 89.0% | US$13.5b | US$128.64 | PS22x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$95.10 | 0.4% | 3.3% | US$18.6b | US$126.60 | PE9.6x | E20.8% | 6.9% | Diversified Financials | ||
SMCI | US$28.52 | -14.3% | -50.8% | US$16.8b | US$40.79 | PE13.8x | E24.3% | n/a | Tech | ||
PLTR | US$82.49 | 4.4% | 384.7% | US$185.0b | US$53.42 | PE394.3x | E28.7% | n/a | Software | ||
NTNX | US$68.77 | 6.3% | 18.8% | US$18.2b | US$81.89 | PS8.3x | E92.0% | n/a | Software | ||
VRT | US$117.02 | -20.0% | 90.4% | US$43.0b | US$143.31 | PE75.5x | E26.8% | 0.1% | Capital Goods | ||
EXE | US$101.60 | -4.2% | 32.7% | US$23.7b | US$117.54 | PE92.4x | E64.0% | 2.3% | Energy | ||
SN | US$111.81 | 1.1% | 129.7% | US$15.9b | US$122.87 | PE43.6x | E22.4% | n/a | Consumer Durables | ||
DASH | US$188.83 | 3.0% | 72.4% | US$78.3b | US$186.03 | PS7.7x | E44.0% | n/a | Consumer Services | ||
RYAN New | US$66.58 | 5.3% | 55.1% | US$17.4b | US$73.98 | PE81.9x | E43.9% | 0.7% | Insurance | ||
CRDO | US$70.02 | -13.0% | 220.5% | US$10.8b | US$79.54 | PS47.7x | E66.2% | n/a | Semiconductors | ||
SPOT | US$548.55 | 7.5% | 146.6% | US$111.2b | US$497.10 | PE152.5x | E26.6% | n/a | Media | ||
SRPT | US$113.72 | -2.4% | -6.2% | US$10.9b | US$185.16 | PE89.2x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
XPEV | US$15.22 | 3.7% | 85.8% | US$14.8b | US$14.77 | PS2.8x | E56.7% | n/a | Automobiles | ||
CTRA | US$27.72 | -4.5% | 12.9% | US$20.9b | US$34.59 | PE16.5x | E25.2% | 3.0% | Energy | ||
ZS | US$202.59 | 4.7% | -17.0% | US$31.1b | US$226.04 | PS13.5x | E39.7% | n/a | Software | ||
CVNA | US$247.48 | 2.9% | 469.6% | US$51.5b | US$253.41 | PE1870.8x | E37.2% | n/a | Retail | ||
ARM | US$159.55 | -1.8% | 124.7% | US$161.0b | US$148.04 | PE261.6x | E31.7% | n/a | Semiconductors |